TELYF (TelyRx Holdings) Total Debt per Share: $0.51 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TELYF TelyRx Holdings Inc TELYF
12 GF Score
Price $1.88
! 2 Warning Signs
View Full Analysis

What is TelyRx Holdings Total Debt per Share?

TelyRx Holdings TELYF +1.62% 12 Total Debt per Share is $0.51 as of Jun. 2026. GuruFocus rates TELYF with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

$0.51 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. TelyRx Holdings's Total Debt Per Share for the quarter that ended in Jun. 2026 was $0.51.

TelyRx Holdings Total Debt per Share Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings Total Debt per Share Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
Total Debt per Share
0.27 0.39 0.48

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only 0.00 0.40 0.48 0.48 0.51
TELYF
12GF Score
TelyRx Holdings Inc TELYF
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings Total Debt per Share Calculation

TelyRx Holdings's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(2.53+9.34)/24.69
=0.48

TelyRx Holdings's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(12.59+0.89)/26.59
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.51 mean?
TelyRx Holdings (TELYF) has a Total Debt per Share of $0.51 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on TelyRx Holdings and its competitors.
Is TelyRx Holdings' Total Debt per Share too high?
TelyRx Holdings' current Total Debt per Share is $0.51. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Total Debt per Share compare to ?
TelyRx Holdings' Total Debt per Share of $0.51 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Healthcare Providers & Services company?
A good Total Debt per Share depends on the Healthcare Providers & Services industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on TelyRx Holdings and its competitors. TelyRx Holdings's current Total Debt per Share is $0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TELYF) has a current Total Debt per Share of $0.51. The current Total Debt per Share is $0.51. TelyRx Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For TelyRx Holdings (TELYF), the current Total Debt per Share is $0.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Comparable Companies
Other Exchanges TELY:Canada
Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TELYF

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price